Implementing the Medical Model in Aesthetic Consultation.

Plast Aesthet Nurs (Phila)

Anna Katherine Wicklund, MSN, NP-C, FNP-BC, CANS, is a nurse practitioner, Elevé Plastic Surgery, Wausau, WI.

Published: December 2022

Throughout the process of building a new medical spa, it is important to standardize and implement safe, evidenced-based practice standards. As medical spas and aesthetic services become more prevalent and popular, it is more important than ever for providers to ensure that patient safety is a top priority. Integrating a structured medical model into the aesthetic consultation and treatment ensures that a mutual decision-making process is shared between the provider and the patient. Together, the provider and the patient can determine whether the treatment will improve the patient's overall health and well-being. The patient is given the opportunity to fully understand and choose which procedure will best address their overall psychological health, aesthetic concern, and anatomical diagnosis. In establishing agreement with the patient on a common goal, the provider can first assess the risks and benefits, and then determine which intervention or treatment will provide the patient with the greatest benefit. When providers establish and adhere to an easy-to-use, decision-making algorithm, patients are empowered in the decision-making process. This helps build a working, trusting relationship between the patient and the provider, which leads to greater patient satisfaction and patient loyalty. Sharing this medical model algorithm will greatly benefit other aesthetic providers by helping to create a standardized evaluation process in a medically based aesthetic practice.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PSN.0000000000000419DOI Listing

Publication Analysis

Top Keywords

medical model
12
patient
9
model aesthetic
8
aesthetic consultation
8
decision-making process
8
provider patient
8
patient provider
8
treatment will
8
aesthetic
6
implementing medical
4

Similar Publications

N-acetyl-tryptophan in Acute Kidney Injury after Cardiac Surgery.

J Am Soc Nephrol

January 2025

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China.

Background: Cardiac surgery-associated acute kidney injury is a common serious complication after cardiac surgery. Currently, there are no specific pharmacological therapies. Our understanding of its pathophysiology remains preliminary.

View Article and Find Full Text PDF

Urinary obstruction causes injury to the renal medulla, impairing the ability to concentrate urine, and increasing the risk of progressive kidney disease. However, the regenerative capacity of the renal medulla after reversal of obstruction is poorly understood. To investigate this, we developed a mouse model of reversible urinary obstruction.

View Article and Find Full Text PDF

Human Oncostatin M deficiency underlies an inherited severe bone marrow failure syndrome.

J Clin Invest

January 2025

Laboratory of Genome Dynamics in the Immune, INSERM UMR 116, Équipe Labellisée LIGUE 2023, Paris, France.

Oncostatin M (OSM) is a cytokine with the unique ability to interact with both the OSM receptor (OSMR) and the leukemia inhibitory factor receptor (LIFR). On the other hand, OSMR interacts with IL31RA to form the interleukin-31 receptor. This intricate network of cytokines and receptors makes it difficult to understand the specific function of OSM.

View Article and Find Full Text PDF

Background: B7-H3 or CD276 is notably overexpressed in various malignant tumor cells in humans, with extremely high expression rates. The development of a radiotracer that targets B7-H3 may provide a universal tumor-specific imaging agent and allow the noninvasive assessment of the whole-body distribution of B7-H3-expressing lesions.

Methods: We enhanced and optimized the structure of an affibody (ABY) that targets B7-H3 to create the radiolabeled radiotracer [68Ga]Ga-B7H3-BCH, and then, we conducted both foundational experiments and clinical translational studies.

View Article and Find Full Text PDF

Objective: This study aims to explore the role of exosome-related genes in breast cancer (BRCA) metastasis by integrating RNA-seq and single-cell RNA-seq (scRNA-seq) data from BRCA samples and to develop a reliable prognostic model.

Methods: Initially, a comprehensive analysis was conducted on exosome-related genes from the BRCA cohort in The Cancer Genome Atlas (TCGA) database. Three prognostic genes (JUP, CAPZA1 and ARVCF) were identified through univariate Cox regression and Lasso-Cox regression analyses, and a metastasis-related risk score model was established based on these genes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!